CDCARE
ActiveSummary
CDCARE has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €218,154 and a net result of €18,938. Equity is growing by about 9.3% per year across the filed financial years. Its solvency ranks better than 86% of 20,461 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2025
23-12
NBB filing
Annual accounts filed
financial year 2025 · micro format
30-06
Financial
Liquidity more than doublescurrent ratio 11.20
Current ratio from 5.19 to 11.20; short-term debt falls from €40,550 to €18,898.
30-06
Financial
Equity above €200,000equity €218,154 ▲9.5%
A profit in every financial year since 2023 builds equity to €218,154.
2024
20-12
NBB filing
Annual accounts filed
financial year 2024 · micro format
30-06
Financial
Weakest financial yearnet €18,293 ▼78.7%
Net result drops to €18,293, the lowest in the series; recovery starts the following year.
2023
26-12
NBB filing
Annual accounts filed
financial year 2023 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.